Download This Paper
Preprints with The Lancet is a collaboration between The Lancet Group of journals and SSRN to facilitate the open sharing of preprints for early engagement, community comment, and collaboration. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early-stage research papers that have not been peer-reviewed. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. The findings should not be used for clinical or public health decision-making or presented without highlighting these facts. For more information, please see the FAQs.
Risk Factors Associated with Severe COVID-19 in Eastern France: Analysis of 1045 Cases
30 Pages Posted: 1 Jun 2020
More...Abstract
Background: In March 2020, the World Health Organization declared Europe as the new epicentre of the coronavirus disease 2019 (COVID-19) pandemic. Chatacteristics associated with poor outcome in this population remain unclear. Our objective was to identify risk factors predictive of severe disease in hospitalised patients.
Methods: In this prospective observational cohort study, we included hospitalised adult patients with confirmed COVID-19, admitted in Strasbourg hospital, and Mulhouse hospital (France) in March 2020. Using multivariate analysis, we compared patients who developed non-severe or severe disease, which was defined by the admission to an intensive care unit or death in the first seven days of hospitalisation.
Findings: 1045 patients were included in this study. Overall, 424 (401%) patients satisfied the composite criteria for severe disease, including 335 (32%) who were admitted to intensive care units, and 111 (11%) who died. The demographic risk factors associated with severe disease were advanced age (odds ratio (OR) 1∙1 per ten-year increase; 95% credible interval (CrI), 1∙0–1∙3), being male (OR 2∙1; 1∙5–2∙8), and having a body mass index of 25–29∙9 (OR 1∙8; 1∙2–2∙7) or ≥30 (OR 2∙2; 1∙5–3∙3). Dyspnoea (OR 2∙5; 1∙8–3∙4), a C-reactive protein level of 100–199 mg/L (OR 1∙7; 1∙2–2∙3) or ≥200 mg/L (OR 4∙2; 2∙6–6∙5), a neutrophil count ≥8000 per µL (OR 2∙1; 1∙4–3∙0), lymphocyte count <1000 per µL (OR 1∙4; 1∙1–1∙9), and treatment with a macrolide in the seven days before hospitalisation (OR 1∙8; 1∙1–2∙7) were also associated with the development of severe disease.
Interpretation: Being overweight, of advanced age, and male, and presenting with dyspnoea and inflammation are risk factors for severe COVID-19 in hospitalised patients. Identifying these features might improve the management of this infection.
Funding Statement: No funding.
Declaration of Interests: No conflict to declare.
Ethics Approval Statement: The study was approved by the Ethics Committee of the University Hospital of Strasbourg (N°CE-2020-51).
Keywords: COVID-19; risk factors; death; Obesity; outcome
Suggested Citation: Suggested Citation